Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Neuromodulation Devices Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Neuromodulation Devices Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Medical Devices & Consumables

Published: 2023-06-02

Pages: 90 Pages

Report ld: 1279858

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Neuromodulation Devices report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neuromodulation Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Pain Management and Parkinson’s Disease are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Neuromodulation Devices industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.

Globally, Neuromodulation Devices key manufacturers include Medtronic, Boston Scientific, Abbott, LivaNova, Nevro, NeuroPace, Beijing Pins and Synapse Biomedical, etc. Medtronic, Boston Scientific, Abbott are top 3 players and held % sales share in total in 2022.

Neuromodulation Devices can be divided into Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS) and Sacral Nerve Stimulation (SNS), etc. Deep Brain Stimulation (DBS) is the mainstream product in the market, accounting for % sales share globally in 2022.

Neuromodulation Devices is widely used in various fields, such as Pain Management, Parkinson’s Disease, Urinary and Fecal Incontinence and Epilepsy, etc. Pain Management provides greatest supports to the Neuromodulation Devices industry development. In 2022, global % sales of Neuromodulation Devices went into Pain Management filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neuromodulation Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical

Segment by Type
Deep Brain Stimulation (DBS)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)

Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other

Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Neuromodulation Devices market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neuromodulation Devices, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neuromodulation Devices industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Neuromodulation Devices in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neuromodulation Devices introduction, etc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Neuromodulation Devices market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Neuromodulation Devices Market Overview
    1.1 Neuromodulation Devices Product Overview
    1.2 Neuromodulation Devices Market Segment by Type
        1.2.1 Deep Brain Stimulation (DBS)
        1.2.2 Spinal Cord Stimulation (SCS)
        1.2.3 Vagus Nerve Stimulation (VNS)
        1.2.4 Sacral Nerve Stimulation (SNS)
        1.2.5 Gastric Electrical Stimulation (GES)
    1.3 Global Neuromodulation Devices Market Size by Type
        1.3.1 Global Neuromodulation Devices Market Size Overview by Type (2018-2029)
        1.3.2 Global Neuromodulation Devices Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Neuromodulation Devices Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Neuromodulation Devices Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Neuromodulation Devices Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Neuromodulation Devices Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Neuromodulation Devices Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Neuromodulation Devices Sales Breakdown by Type (2018-2023)

 2 Global Neuromodulation Devices Market Competition by Company
    2.1 Global Top Players by Neuromodulation Devices Sales (2018-2023)
    2.2 Global Top Players by Neuromodulation Devices Revenue (2018-2023)
    2.3 Global Top Players by Neuromodulation Devices Price (2018-2023)
    2.4 Global Top Manufacturers Neuromodulation Devices Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Neuromodulation Devices Market Competitive Situation and Trends
        2.5.1 Neuromodulation Devices Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Neuromodulation Devices Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulation Devices as of 2022)
    2.7 Date of Key Manufacturers Enter into Neuromodulation Devices Market
    2.8 Key Manufacturers Neuromodulation Devices Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Neuromodulation Devices Status and Outlook by Region
    3.1 Global Neuromodulation Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Neuromodulation Devices Historic Market Size by Region
        3.2.1 Global Neuromodulation Devices Sales in Volume by Region (2018-2023)
        3.2.2 Global Neuromodulation Devices Sales in Value by Region (2018-2023)
        3.2.3 Global Neuromodulation Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Neuromodulation Devices Forecasted Market Size by Region
        3.3.1 Global Neuromodulation Devices Sales in Volume by Region (2024-2029)
        3.3.2 Global Neuromodulation Devices Sales in Value by Region (2024-2029)
        3.3.3 Global Neuromodulation Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Neuromodulation Devices by Application
    4.1 Neuromodulation Devices Market Segment by Application
        4.1.1 Pain Management
        4.1.2 Parkinson’s Disease
        4.1.3 Urinary and Fecal Incontinence
        4.1.4 Epilepsy
        4.1.5 Gastroparesis
        4.1.6 Other
    4.2 Global Neuromodulation Devices Market Size by Application
        4.2.1 Global Neuromodulation Devices Market Size Overview by Application (2018-2029)
        4.2.2 Global Neuromodulation Devices Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Neuromodulation Devices Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Neuromodulation Devices Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Neuromodulation Devices Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Neuromodulation Devices Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Neuromodulation Devices Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Neuromodulation Devices Sales Breakdown by Application (2018-2023)

 5 North America Neuromodulation Devices by Country
    5.1 North America Neuromodulation Devices Historic Market Size by Country
        5.1.1 North America Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Neuromodulation Devices Sales in Volume by Country (2018-2023)
        5.1.3 North America Neuromodulation Devices Sales in Value by Country (2018-2023)
    5.2 North America Neuromodulation Devices Forecasted Market Size by Country
        5.2.1 North America Neuromodulation Devices Sales in Volume by Country (2024-2029)
        5.2.2 North America Neuromodulation Devices Sales in Value by Country (2024-2029)

 6 Europe Neuromodulation Devices by Country
    6.1 Europe Neuromodulation Devices Historic Market Size by Country
        6.1.1 Europe Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Neuromodulation Devices Sales in Volume by Country (2018-2023)
        6.1.3 Europe Neuromodulation Devices Sales in Value by Country (2018-2023)
    6.2 Europe Neuromodulation Devices Forecasted Market Size by Country
        6.2.1 Europe Neuromodulation Devices Sales in Volume by Country (2024-2029)
        6.2.2 Europe Neuromodulation Devices Sales in Value by Country (2024-2029)

 7 Asia-Pacific Neuromodulation Devices by Region
    7.1 Asia-Pacific Neuromodulation Devices Historic Market Size by Region
        7.1.1 Asia-Pacific Neuromodulation Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Neuromodulation Devices Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Neuromodulation Devices Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Neuromodulation Devices Forecasted Market Size by Region
        7.2.1 Asia-Pacific Neuromodulation Devices Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Neuromodulation Devices Sales in Value by Region (2024-2029)

 8 Latin America Neuromodulation Devices by Country
    8.1 Latin America Neuromodulation Devices Historic Market Size by Country
        8.1.1 Latin America Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Neuromodulation Devices Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Neuromodulation Devices Sales in Value by Country (2018-2023)
    8.2 Latin America Neuromodulation Devices Forecasted Market Size by Country
        8.2.1 Latin America Neuromodulation Devices Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Neuromodulation Devices Sales in Value by Country (2024-2029)

 9 Middle East and Africa Neuromodulation Devices by Country
    9.1 Middle East and Africa Neuromodulation Devices Historic Market Size by Country
        9.1.1 Middle East and Africa Neuromodulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Neuromodulation Devices Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Neuromodulation Devices Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Neuromodulation Devices Forecasted Market Size by Country
        9.2.1 Middle East and Africa Neuromodulation Devices Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Neuromodulation Devices Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Medtronic
        10.1.1 Medtronic Company Information
        10.1.2 Medtronic Introduction and Business Overview
        10.1.3 Medtronic Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Medtronic Neuromodulation Devices Products Offered
        10.1.5 Medtronic Recent Development
    10.2 Boston Scientific
        10.2.1 Boston Scientific Company Information
        10.2.2 Boston Scientific Introduction and Business Overview
        10.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Boston Scientific Neuromodulation Devices Products Offered
        10.2.5 Boston Scientific Recent Development
    10.3 Abbott
        10.3.1 Abbott Company Information
        10.3.2 Abbott Introduction and Business Overview
        10.3.3 Abbott Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Abbott Neuromodulation Devices Products Offered
        10.3.5 Abbott Recent Development
    10.4 LivaNova
        10.4.1 LivaNova Company Information
        10.4.2 LivaNova Introduction and Business Overview
        10.4.3 LivaNova Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 LivaNova Neuromodulation Devices Products Offered
        10.4.5 LivaNova Recent Development
    10.5 Nevro
        10.5.1 Nevro Company Information
        10.5.2 Nevro Introduction and Business Overview
        10.5.3 Nevro Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Nevro Neuromodulation Devices Products Offered
        10.5.5 Nevro Recent Development
    10.6 NeuroPace
        10.6.1 NeuroPace Company Information
        10.6.2 NeuroPace Introduction and Business Overview
        10.6.3 NeuroPace Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 NeuroPace Neuromodulation Devices Products Offered
        10.6.5 NeuroPace Recent Development
    10.7 Beijing Pins
        10.7.1 Beijing Pins Company Information
        10.7.2 Beijing Pins Introduction and Business Overview
        10.7.3 Beijing Pins Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Beijing Pins Neuromodulation Devices Products Offered
        10.7.5 Beijing Pins Recent Development
    10.8 Synapse Biomedical
        10.8.1 Synapse Biomedical Company Information
        10.8.2 Synapse Biomedical Introduction and Business Overview
        10.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Synapse Biomedical Neuromodulation Devices Products Offered
        10.8.5 Synapse Biomedical Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Neuromodulation Devices Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Neuromodulation Devices Industrial Chain Analysis
    11.4 Neuromodulation Devices Market Dynamics
        11.4.1 Neuromodulation Devices Industry Trends
        11.4.2 Neuromodulation Devices Market Drivers
        11.4.3 Neuromodulation Devices Market Challenges
        11.4.4 Neuromodulation Devices Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Neuromodulation Devices Distributors
    12.3 Neuromodulation Devices Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Deep Brain Stimulation (DBS)
    Table 2. Major Company of Spinal Cord Stimulation (SCS)
    Table 3. Major Company of Vagus Nerve Stimulation (VNS)
    Table 4. Major Company of Sacral Nerve Stimulation (SNS)
    Table 5. Major Company of Gastric Electrical Stimulation (GES)
    Table 6. Global Neuromodulation Devices Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Neuromodulation Devices Sales by Type (2018-2023) & (K Units)
    Table 8. Global Neuromodulation Devices Sales Market Share in Volume by Type (2018-2023)
    Table 9. Global Neuromodulation Devices Sales by Type (2018-2023) & (US& Million)
    Table 10. Global Neuromodulation Devices Market Share in Value by Type (2018-2023)
    Table 11. Global Neuromodulation Devices Price by Type (2018-2023) & (USD/Unit)
    Table 12. Global Neuromodulation Devices Sales by Type (2024-2029) & (K Units)
    Table 13. Global Neuromodulation Devices Sales Market Share in Volume by Type (2024-2029)
    Table 14. Global Neuromodulation Devices Sales by Type (2024-2029) & (US$ Million)
    Table 15. Global Neuromodulation Devices Sales Market Share in Value by Type (2024-2029)
    Table 16. Global Neuromodulation Devices Price by Type (2024-2029) & (USD/Unit)
    Table 17. North America Neuromodulation Devices Sales by Type (2018-2023) & (K Units)
    Table 18. North America Neuromodulation Devices Sales by Type (2018-2023) & (US$ Million)
    Table 19. Europe Neuromodulation Devices Sales (K Units) by Type (2018-2023)
    Table 20. Europe Neuromodulation Devices Sales by Type (2018-2023) & (US$ Million)
    Table 21. Asia-Pacific Neuromodulation Devices Sales (K Units) by Type (2018-2023)
    Table 22. Asia-Pacific Neuromodulation Devices Sales by Type (2018-2023) & (US$ Million)
    Table 23. Latin America Neuromodulation Devices Sales (K Units) by Type (2018-2023)
    Table 24. Latin America Neuromodulation Devices Sales by Type (2018-2023) & (US$ Million)
    Table 25. Middle East and Africa Neuromodulation Devices Sales (K Units) by Type (2018-2023)
    Table 26. Middle East and Africa Neuromodulation Devices Sales by Type (2018-2023) & (US$ Million)
    Table 27. Global Neuromodulation Devices Sales by Company (2018-2023) & (K Units)
    Table 28. Global Neuromodulation Devices Sales Share by Company (2018-2023)
    Table 29. Global Neuromodulation Devices Revenue by Company (2018-2023) & (US$ Million)
    Table 30. Global Neuromodulation Devices Revenue Share by Company (2018-2023)
    Table 31. Global Market Neuromodulation Devices Price by Company (2018-2023) & (USD/Unit)
    Table 32. Global Neuromodulation Devices Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 33. Global Neuromodulation Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulation Devices as of 2022)
    Table 35. Date of Key Manufacturers Enter into Neuromodulation Devices Market
    Table 36. Key Manufacturers Neuromodulation Devices Product Type
    Table 37. Mergers & Acquisitions, Expansion Plans
    Table 38. Global Neuromodulation Devices Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Global Neuromodulation Devices Sales by Region (2018-2023) & (K Units)
    Table 40. Global Neuromodulation Devices Sales Market Share in Volume by Region (2018-2023)
    Table 41. Global Neuromodulation Devices Sales by Region (2018-2023) & (US$ Million)
    Table 42. Global Neuromodulation Devices Sales Market Share in Value by Region (2018-2023)
    Table 43. Global Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 44. Global Neuromodulation Devices Sales by Region (2024-2029) & (K Units)
    Table 45. Global Neuromodulation Devices Sales Market Share in Volume by Region (2024-2029)
    Table 46. Global Neuromodulation Devices Sales by Region (2024-2029) & (US$ Million)
    Table 47. Global Neuromodulation Devices Sales Market Share in Value by Region (2024-2029)
    Table 48. Global Neuromodulation Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 49. Global Neuromodulation Devices Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 50. Global Neuromodulation Devices Sales by Application (2018-2023) & (K Units)
    Table 51. Global Neuromodulation Devices Sales Market Share in Volume by Application (2018-2023)
    Table 52. Global Neuromodulation Devices Sales by Application (2018-2023) & (US$ Million)
    Table 53. Global Neuromodulation Devices Sales Market Share in Value by Application (2018-2023)
    Table 54. Global Neuromodulation Devices Price by Application (2018-2023) & (USD/Unit)
    Table 55. Global Neuromodulation Devices Sales by Application (2024-2029) & (K Units)
    Table 56. Global Neuromodulation Devices Sales Market Share in Volume by Application (2024-2029)
    Table 57. Global Neuromodulation Devices Sales by Application (2024-2029) & (US$ Million)
    Table 58. Global Neuromodulation Devices Sales Market Share in Value by Application (2024-2029)
    Table 59. Global Neuromodulation Devices Price by Application (2024-2029) & (USD/Unit)
    Table 60. North America Neuromodulation Devices Sales by Application (2018-2023) (K Units) 
    Table 61. North America Neuromodulation Devices Sales by Application (2018-2023) & (US$ Million)
    Table 62. Europe Neuromodulation Devices Sales by Application (2018-2023) (K Units) 
    Table 63. Europe Neuromodulation Devices Sales by Application (2018-2023) & (US$ Million)
    Table 64. Asia-Pacific Neuromodulation Devices Sales by Application (2018-2023) (K Units) 
    Table 65. Asia-Pacific Neuromodulation Devices Sales by Application (2018-2023) & (US$ Million)
    Table 66. Latin America Neuromodulation Devices Sales by Application (2018-2023) (K Units) 
    Table 67. Latin America Neuromodulation Devices Sales by Application (2018-2023) & (US$ Million)
    Table 68. Middle East and Africa Neuromodulation Devices Sales by Application (2018-2023) (K Units) 
    Table 69. Middle East and Africa Neuromodulation Devices Sales by Application (2018-2023) & (US$ Million)
    Table 70. North America Neuromodulation Devices Sales by Country (2018-2023) & (K Units)
    Table 71. North America Neuromodulation Devices Sales Market Share in Volume by Country (2018-2023)
    Table 72. North America Neuromodulation Devices Sales by Country (2018-2023) & (US$ Million)
    Table 73. North America Neuromodulation Devices Sales Market Share in Value by Country (2018-2023)
    Table 74. North America Neuromodulation Devices Sales by Country (2024-2029) & (K Units)
    Table 75. North America Neuromodulation Devices Sales Market Share in Volume by Country (2024-2029)
    Table 76. North America Neuromodulation Devices Sales by Country (2024-2029) & (US$ Million)
    Table 77. North America Neuromodulation Devices Sales Market Share in Value by Country (2024-2029)
    Table 78. Europe Neuromodulation Devices Sales by Country (2018-2023) & (K Units)
    Table 79. Europe Neuromodulation Devices Sales Market Share in Volume by Country (2018-2023)
    Table 80. Europe Neuromodulation Devices Sales by Country (2018-2023) & (US$ Million)
    Table 81. Europe Neuromodulation Devices Sales Market Share in Value by Country (2018-2023)
    Table 82. Europe Neuromodulation Devices Sales by Country (2024-2029) & (K Units)
    Table 83. Europe Neuromodulation Devices Sales Market Share in Volume by Country (2024-2029)
    Table 84. Europe Neuromodulation Devices Sales by Country (2024-2029) & (US$ Million)
    Table 85. Europe Neuromodulation Devices Sales Market Share in Value by Country (2024-2029)
    Table 86. Asia-Pacific Neuromodulation Devices Sales by Region (2018-2023) & (K Units)
    Table 87. Asia-Pacific Neuromodulation Devices Sales Market Share in Volume by Region (2018-2023)
    Table 88. Asia-Pacific Neuromodulation Devices Sales by Region (2018-2023) & (US$ Million)
    Table 89. Asia-Pacific Neuromodulation Devices Sales Market Share in Value by Region (2018-2023)
    Table 90. Asia-Pacific Neuromodulation Devices Sales by Region (2024-2029) & (K Units)
    Table 91. Asia-Pacific Neuromodulation Devices Sales Market Share in Volume by Region (2024-2029)
    Table 92. Asia-Pacific Neuromodulation Devices Sales by Region (2024-2029) & (US$ Million)
    Table 93. Asia-Pacific Neuromodulation Devices Sales Market Share in Value by Region (2024-2029)
    Table 94. Latin America Neuromodulation Devices Sales by Country (2018-2023) & (K Units)
    Table 95. Latin America Neuromodulation Devices Sales Market Share in Volume by Country (2018-2023)
    Table 96. Latin America Neuromodulation Devices Sales by Country (2018-2023) & (US$ Million)
    Table 97. Latin America Neuromodulation Devices Sales Market Share in Value by Country (2018-2023)
    Table 98. Latin America Neuromodulation Devices Sales by Country (2024-2029) & (K Units)
    Table 99. Latin America Neuromodulation Devices Sales Market Share in Volume by Country (2024-2029)
    Table 100. Latin America Neuromodulation Devices Sales by Country (2024-2029) & (US$ Million)
    Table 101. Latin America Neuromodulation Devices Sales Market Share in Value by Country (2024-2029)
    Table 102. Middle East and Africa Neuromodulation Devices Sales by Country (2018-2023) & (K Units)
    Table 103. Middle East and Africa Neuromodulation Devices Sales Market Share in Volume by Country (2018-2023)
    Table 104. Middle East and Africa Neuromodulation Devices Sales by Country (2018-2023) & (US$ Million)
    Table 105. Middle East and Africa Neuromodulation Devices Sales Market Share in Value by Country (2018-2023)
    Table 106. Middle East and Africa Neuromodulation Devices Sales by Country (2024-2029) & (K Units)
    Table 107. Middle East and Africa Neuromodulation Devices Sales Market Share in Volume by Country (2024-2029)
    Table 108. Middle East and Africa Neuromodulation Devices Sales by Country (2024-2029) & (US$ Million)
    Table 109. Middle East and Africa Neuromodulation Devices Sales Market Share in Value by Country (2024-2029)
    Table 110. Medtronic Company Information
    Table 111. Medtronic Introduction and Business Overview
    Table 112. Medtronic Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Medtronic Neuromodulation Devices Product
    Table 114. Medtronic Recent Development
    Table 115. Boston Scientific Company Information
    Table 116. Boston Scientific Introduction and Business Overview
    Table 117. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Boston Scientific Neuromodulation Devices Product
    Table 119. Boston Scientific Recent Development
    Table 120. Abbott Company Information
    Table 121. Abbott Introduction and Business Overview
    Table 122. Abbott Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Abbott Neuromodulation Devices Product
    Table 124. Abbott Recent Development
    Table 125. LivaNova Company Information
    Table 126. LivaNova Introduction and Business Overview
    Table 127. LivaNova Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. LivaNova Neuromodulation Devices Product
    Table 129. LivaNova Recent Development
    Table 130. Nevro Company Information
    Table 131. Nevro Introduction and Business Overview
    Table 132. Nevro Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Nevro Neuromodulation Devices Product
    Table 134. Nevro Recent Development
    Table 135. NeuroPace Company Information
    Table 136. NeuroPace Introduction and Business Overview
    Table 137. NeuroPace Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 138. NeuroPace Neuromodulation Devices Product
    Table 139. NeuroPace Recent Development
    Table 140. Beijing Pins Company Information
    Table 141. Beijing Pins Introduction and Business Overview
    Table 142. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 143. Beijing Pins Neuromodulation Devices Product
    Table 144. Beijing Pins Recent Development
    Table 145. Synapse Biomedical Company Information
    Table 146. Synapse Biomedical Introduction and Business Overview
    Table 147. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 148. Synapse Biomedical Neuromodulation Devices Product
    Table 149. Synapse Biomedical Recent Development
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Neuromodulation Devices Market Trends
    Table 153. Neuromodulation Devices Market Drivers
    Table 154. Neuromodulation Devices Market Challenges
    Table 155. Neuromodulation Devices Market Restraints
    Table 156. Neuromodulation Devices Distributors List
    Table 157. Neuromodulation Devices Downstream Customers
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neuromodulation Devices Product Picture
    Figure 2. Global Neuromodulation Devices Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Neuromodulation Devices Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Neuromodulation Devices Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Deep Brain Stimulation (DBS)
    Figure 6. Global Deep Brain Stimulation (DBS) Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Spinal Cord Stimulation (SCS)
    Figure 8. Global Spinal Cord Stimulation (SCS) Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Vagus Nerve Stimulation (VNS)
    Figure 10. Global Vagus Nerve Stimulation (VNS) Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Product Picture of Sacral Nerve Stimulation (SNS)
    Figure 12. Global Sacral Nerve Stimulation (SNS) Sales YoY Growth (2018-2029) & (K Units)
    Figure 13. Product Picture of Gastric Electrical Stimulation (GES)
    Figure 14. Global Gastric Electrical Stimulation (GES) Sales YoY Growth (2018-2029) & (K Units)
    Figure 15. Global Neuromodulation Devices Sales by Type (2018-2029) & (US$ Million)
    Figure 16. Global Neuromodulation Devices Sales Market Share by Type in 2022 & 2029
    Figure 17. North America Neuromodulation Devices Sales Market Share in Volume by Type in 2022
    Figure 18. North America Neuromodulation Devices Sales Market Share in Value by Type in 2022
    Figure 19. Europe Neuromodulation Devices Sales Market Share in Volume by Type in 2022
    Figure 20. Europe Neuromodulation Devices Sales Market Share in Value by Type in 2022
    Figure 21. Asia-Pacific Neuromodulation Devices Sales Market Share in Volume by Type in 2022
    Figure 22. Asia-Pacific Neuromodulation Devices Sales Market Share in Value by Type in 2022
    Figure 23. Latin America Neuromodulation Devices Sales Market Share in Volume by Type in 2022
    Figure 24. Latin America Neuromodulation Devices Sales Market Share in Value by Type in 2022
    Figure 25. Middle East and Africa Neuromodulation Devices Sales Market Share in Volume by Type in 2022
    Figure 26. Middle East and Africa Neuromodulation Devices Sales Market Share in Value by Type in 2022
    Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuromodulation Devices Sales in 2022
    Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuromodulation Devices Revenue in 2022
    Figure 29. Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 30. Product Picture of Pain Management
    Figure 31. Global Pain Management Sales YoY Growth (2018-2029) & (K Units)
    Figure 32. Product Picture of Parkinson’s Disease
    Figure 33. Global Parkinson’s Disease Sales YoY Growth (2018-2029) & (K Units)
    Figure 34. Product Picture of Urinary and Fecal Incontinence
    Figure 35. Global Urinary and Fecal Incontinence Sales YoY Growth (2018-2029) & (K Units)
    Figure 36. Product Picture of Epilepsy
    Figure 37. Global Epilepsy Sales YoY Growth (2018-2029) & (K Units)
    Figure 38. Product Picture of Gastroparesis
    Figure 39. Global Gastroparesis Sales YoY Growth (2018-2029) & (K Units)
    Figure 40. Product Picture of Other
    Figure 41. Global Other Sales YoY Growth (2018-2029) & (K Units)
    Figure 42. Global Neuromodulation Devices Sales by Application (2018-2029) & (US$ Million)
    Figure 43. Global Neuromodulation Devices Sales Market Share by Application in 2022 & 2029
    Figure 44. North America Neuromodulation Devices Sales Market Share in Volume by Application in 2022
    Figure 45. North America Neuromodulation Devices Sales Market Share in Value by Application in 2022
    Figure 46. Europe Neuromodulation Devices Sales Market Share in Volume by Application in 2022
    Figure 47. Europe Neuromodulation Devices Sales Market Share in Value by Application in 2022
    Figure 48. Asia-Pacific Neuromodulation Devices Sales Market Share in Volume by Application in 2022
    Figure 49. Asia-Pacific Neuromodulation Devices Sales Market Share in Value by Application in 2022
    Figure 50. Latin America Neuromodulation Devices Sales Market Share in Volume by Application in 2022
    Figure 51. Latin America Neuromodulation Devices Sales Market Share in Value by Application in 2022
    Figure 52. Middle East and Africa Neuromodulation Devices Sales Market Share in Value by Application in 2022
    Figure 53. Key Raw Materials Price
    Figure 54. Neuromodulation Devices Manufacturing Cost Structure
    Figure 55. Neuromodulation Devices Industrial Chain Analysis
    Figure 56. Channels of Distribution
    Figure 57. Distributors Profiles
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed

Neuromodulation Devices report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neuromodulation Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Pain Management and Parkinson’s Disease are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Neuromodulation Devices industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical

Segment by Type
Deep Brain Stimulation (DBS)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)

Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other

Industry: Medical Devices & Consumables

Published: 2023-06-02

Pages: 90 Pages

Report ld: 1279858

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License

USD 6700.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?